-
OLINK Services (Explore, Target & Flex)
comprehensive overview of protein expression levels on Olink® Explore, Target and Flex platforms!
-
PROTEOMICS Services
Absolute protein quantification, ultra-low quantification (Quanterix™), large-scale protein identification (Olink®)
-
GENOMICS Services
Next Generation Sequencing, Single cell sequencing, Spatial Transcriptomics and custom RT-qPCR
-
ASSAY DEVELOPMENT & PRODUCTION
We provide assay development services and produce biological material and IVD kits.
-
NEUROLINCS
targeted sequencing panel that quantifies ~7500 brain enriched lncRNAs associated with cognitive impairment, Alzheimer's, and other neurodegenerative diseases
-
BIOPRED
an mRNA based targeted gene sequencing panel to better understand inflammatory-autoimmune disorders
-
FIMICS
a long non-coding RNA panel to better characterize patients with cardiac disorders and toxicities
-
ELISA KITS
Colorimetric sandwich ELISA kits developed and validated for biomarker measurement in blood-derived matrices samples
the reliable partner
since its creation, Firalis has been awarded for and contributed in
100+ clinical and pre-clinical research projects in biomarkers,
playing a leading role towards the setting of industry gold standards
for the discovery, development and qualification of
novel biomarkers for clinical and pre-clinical applications!
Why Firalis
Firalis has a comprehensive range of know-how for biomarker discovery up to clinical qualification, develops and commercializes biomarker tests, RUO and IVD tools.
Who we are
Firalis projects target qualification of biomarkers for various clinical applications.
As the initiator of SAFE-T consortium, Firalis validates and develops biomarker panels, following strictly EMA and FDA directions.
What we do
Our production facilities are GMP compliant, certified "ISO 13485" for medical device manufacture, and "ISO 17025",
being the most important quality standard
for calibration and testing.
Recent news at Firalis
07.04.2023
05.04.2023
09.08.2022
11.07.2022